Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Mesa Laboratories (MLAB) over the last 16 years, with Q4 2025 value amounting to $819000.0.

  • Mesa Laboratories' Change in Receivables rose 22465.75% to $819000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.1 million, marking a year-over-year decrease of 3579.53%. This contributed to the annual value of $2.9 million for FY2025, which is 15921.05% up from last year.
  • Mesa Laboratories' Change in Receivables amounted to $819000.0 in Q4 2025, which was up 22465.75% from $1.7 million recorded in Q3 2025.
  • Over the past 5 years, Mesa Laboratories' Change in Receivables peaked at $4.5 million during Q1 2022, and registered a low of -$6.5 million during Q2 2023.
  • Moreover, its 5-year median value for Change in Receivables was $1.1 million (2022), whereas its average is $440400.0.
  • In the last 5 years, Mesa Laboratories' Change in Receivables tumbled by 53504.04% in 2023 and then soared by 226197.18% in 2024.
  • Quarter analysis of 5 years shows Mesa Laboratories' Change in Receivables stood at $3.3 million in 2021, then plummeted by 120.4% to -$678000.0 in 2022, then tumbled by 319.76% to -$2.8 million in 2023, then soared by 76.91% to -$657000.0 in 2024, then skyrocketed by 224.66% to $819000.0 in 2025.
  • Its Change in Receivables stands at $819000.0 for Q4 2025, versus $1.7 million for Q3 2025 and -$3.4 million for Q2 2025.